The Biden administration released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.
This could be the thin edge of the wedge that opens things up. Even countries with pharmacare don’t negotiate all drugs, they have an approved list. Once the list exists, we can gradually expand it. So this is a huge change.
I think it’s good to always fight for more, but I think it’s self sabotaging when even wins like this are treated as failures.